Cholesterol-Lowering Drugs Show Potential To Enhance Survival Rates In Blood Cancer Patients

Researchers from the University of Sharjah and Burjeel Cancer Institute, alongside international collaborators, have discovered that statins, typically used to lower cholesterol, might boost survival rates in certain blood cancer patients. This study, led by Dr. Ahmad Abuhelwa, involved experts from Harvard University, Moffitt Cancer Center, and Flinders University.

The research focused on chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) patients using statins during modern targeted therapies like ibrutinib. Findings showed a 61% reduction in cancer mortality, a 38% decrease in overall mortality, and a 26% lower risk of disease progression for these patients. Importantly, statin use did not increase severe side effects.

Dr. Karem Alzoubi from the University of Sharjah highlighted the faculty's dedication to impactful research addressing healthcare challenges. He emphasized the university's commitment to supporting scientific studies with advanced infrastructure and fostering global collaborations to enhance research quality.

Dr. Ahmad Abuhelwa explained that this is the first systematic evaluation linking statin use with survival outcomes in CLL or SLL patients receiving targeted therapies. The study analyzed data from 1,467 participants across four international clinical trials conducted between 2012 and 2019. These findings suggest potential benefits for patients worldwide.

Despite promising results, Dr. Abuhelwa cautioned against recommending statins as a cancer treatment based solely on this observational study. He stressed the need for future clinical trials to confirm whether statins can be used as supportive treatments in this context.

Global Recognition and Impact

The study's findings were published in the medical journal Blood Advances and have gained attention from major media outlets like The Telegraph and Daily Mail. The results have been translated into multiple languages, including Spanish and Japanese, highlighting their international significance.

Prof. Humaid Al Shamsi of Burjeel Cancer Institute noted that oncologists constantly seek safe ways to improve patient survival. He remarked on the exciting possibility that statins could enhance treatment outcomes without additional risks.

This research underscores the importance of continued investigation into existing medications' potential benefits for cancer patients. By exploring new uses for established drugs like statins, researchers hope to improve treatment options and outcomes for those affected by complex diseases such as cancer.

With inputs from WAM